We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$408B
AUM Growth
+$23B
Cap. Flow
+$1.72B
Cap. Flow %
0.42%
Top 10 Hldgs %
28.09%
Holding
14,143
New
3,275
Increased
5,446
Reduced
4,187
Closed
1,034

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$627M
2
BIDU icon
Baidu
BIDU
+$542M
3
MBB icon
iShares MBS ETF
MBB
+$492M
4
NVDA icon
NVIDIA
NVDA
+$429M
5
CMCSA icon
Comcast
CMCSA
+$421M

Sector Composition

Rank Sector Weight
1 Technology 3.73%
2 Healthcare 3.22%
3 Consumer Discretionary 2.4%
4 Financials 2.32%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCI
12851
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$37K ﹤0.01%
+326
New +$36.1K
BLUA.WS
12852
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$37K ﹤0.01%
+59,182
New +$53.5K
ALYA
12853
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$37K ﹤0.01%
+15,223
New +$37.3K
CSCI
12854
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$36K ﹤0.01%
+316
New +$35K
CYTO
12855
CALL
DELISTED
Altamira Therapeutics Ltd
CYTO
$36K ﹤0.01%
+26
New +$34.8K
MONDW
12856
DELISTED
Mondee Holdings, Inc. Warrant
MONDW
$36K ﹤0.01%
+41,994
New +$30.4K
AXU
12857
CALL
DELISTED
Alexco Resource Corp
AXU
$36K ﹤0.01%
14,200
-110,500
-89% -$304K
ZNB
12858
Zeta Network Group
ZNB
$2.27M
0
ATXS
12859
CALL
DELISTED
Astria Therapeutics
ATXS
$35K ﹤0.01%
2,017
-3,833
-66% -$69.2K
TRX icon
12860
PUT
TRX Gold Corp
TRX
$341M
$35K ﹤0.01%
59,200
+27,100
+84% +$18.9K
NYMX
12861
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
$35K ﹤0.01%
+15,600
New +$41.1K
GMBTW
12862
DELISTED
Pivotal Holdings Corp Warrant
GMBTW
$35K ﹤0.01%
+31,404
New +$36K
EUSGW
12863
DELISTED
European Sustainable Growth Acquisition Corp. Warrant
EUSGW
$35K ﹤0.01%
+50,100
New +$44.5K
AVTX icon
12864
PUT
Avalo Therapeutics
AVTX
$1.04B
$34K ﹤0.01%
+4
New +$37.8K
BEST
12865
CALL
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$34K ﹤0.01%
915
-1,075
-54% -$48.9K
GPL
12866
CALL
DELISTED
Great Panther Mining Limited
GPL
$34K ﹤0.01%
4,360
-1,910
-30% -$16.6K
DALN
12867
DELISTED
DallasNews
DALN
$33K ﹤0.01%
3,967
+1,062
+37% +$9.25K
DLNG icon
12868
PUT
Dynagas LNG Partners
DLNG
$135M
$33K ﹤0.01%
+11,600
New +$32.9K
IMNN icon
12869
Imunon
IMNN
$6.64M
$33K ﹤0.01%
+124
New +$41.7K
PHX
12870
PUT
DELISTED
PHX Minerals
PHX
$33K ﹤0.01%
+11,500
New +$35.2K
TLSA icon
12871
CALL
Tiziana Life Sciences
TLSA
$126M
$33K ﹤0.01%
12,000
-10,200
-46% -$33.8K
AUTO
12872
PUT
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$33K ﹤0.01%
+12,400
New +$36.7K
XELA
12873
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$33K ﹤0.01%
+4
New +$40.1K
SYNC
12874
DELISTED
Synacor, Inc.
SYNC
$33K ﹤0.01%
+14,916
New +$29.2K
IRR
12875
DELISTED
VOYA NATURAL RESOURCES EQUITY INCOME FUND
IRR
$33K ﹤0.01%
+10,027
New +$29.6K

Similar funds

Ken Griffin's Q1 2021 Portfolio in Review

As of Q1 2021, Ken Griffin held 14,143 positions worth $408B, up 6% from $385B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q1 2021 filing shows 3,275 new, 5,446 increased, 4,187 reduced and 1,034 closed positions. Its largest new stake was SVB Financial Group: 445,853 shares worth $220M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.29B.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3.7% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q1 2021 buy was SVB Financial Group: 445,853 shares worth $220M.
  • Ken Griffin added most to Amazon in Q1 2021, an estimated $627M increase.
  • Ken Griffin's biggest Q1 2021 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.29B.
  • Ken Griffin fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $321M.
  • Ken Griffin's ten largest holdings make up 28% of its $408B portfolio in Q1 2021.
  • Ken Griffin opened 3,275 new positions and closed 1,034 in Q1 2021.
  • Ken Griffin's portfolio value rose 6% quarter-over-quarter to $408B.

Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.